Mannkind (MNKD) Net Margin (2010 - 2026)

Mannkind (MNKD) reported Net Margin of 18.43% for Q1 2026, down 3522.0% year-over-year from 0.54% in Q1 2025, and up 1.26% quarter-over-quarter from 18.67% in Q4 2025.

Mannkind (MNKD) Net Margin (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 14 years of Net Margin data on file, last reported at 18.43% in Q1 2026.

  • Net Margin for Q1 2026 came in at 18.43%, down 3522.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.0% (down 1812.0% YoY), and the FY2025 annual result was 0.26%, down 940.0% from the prior year.
  • Net Margin climbed to 18.43% in Q1 2026 per MNKD's latest filing, from 18.67% in the prior quarter.
  • Over five years, Net Margin peaked at 16.79% in Q1 2025 and troughed at 9674.33% in Q2 2022.
  • A 5-year average of 587.1% and a median of 2.78% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2023: Net Margin sank 952174 bps in 2022, then surged 966350 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 49.77% in 2022, then soared by 105 bps to 2.41% in 2023, then soared by 301 bps to 9.66% in 2024, then slumped by 293 bps to 18.67% in 2025, then rose by 1 bps to 18.43% in 2026.
  • Business Quant data shows MNKD's Net Margin at 18.43% in Q1 2026, 18.67% in Q4 2025, and 9.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn -18.43%

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.43%
Dec 31, 2025 -18.67%
Sep 30, 2025 9.72%
Jun 30, 2025 0.87%
Mar 31, 2025 16.79%
Dec 31, 2024 9.66%
Sep 30, 2024 16.48%
Jun 30, 2024 -2.78%
Mar 31, 2024 16.04%
Dec 31, 2023 2.41%
Sep 30, 2023 6.98%
Jun 30, 2023 -10.83%
Mar 31, 2023 -24.11%
Dec 31, 2022 -49.77%
Sep 30, 2022 -43.97%
Jun 30, 2022 -9,674.33%
Mar 31, 2022 -216.79%
Dec 31, 2021 -224.22%
Sep 30, 2021 -19.93%
Jun 30, 2021 -152.59%